PENTOXIFYLLINE ENHANCES IN VITRO T-CELL ANTITUMOR RESPONSE IN BREAST CANCER PATIENTS
The NF-κB transcription factor controls the expression of genes responsible for cell cycle, apoptosis, and other immunoregulatory functions. Some nonspecific NF-κB inhibitors were found after discovering the possibility of blocking tumor growth through suppression of NF-κB activity, but their use wa...
Guardado en:
Autores principales: | M. S. Kuznetsova, J. A. Shevchenko, J. N. Khantakova, A. A. Khristin, I. A. Obleukhova, A. N. Silkov, S. V. Sidorov, S. V. Sennikov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/665db60d517d4864b608bc5c4ed8e1ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
QUANTITATIVE EXPRESSION FEATURES OF PD-1 AND TIM-3 CHECKPOINT MOLECULE RECEPTORS ON CD4⁺ AND CD8⁺ T-CELLS IN BREAST CANCER OF VARYING PROGRESSION DEGREES
por: Yu. A. Shevchenko, et al.
Publicado: (2021) -
Effects of pentoxifylline on canine platelet aggregation
por: John M. Thomason, et al.
Publicado: (2021) -
Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine
por: Sahar M. El‑Haggar, et al.
Publicado: (2022) -
In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells
por: Hernandez-Delgadillo R, et al.
Publicado: (2018) -
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Wiktoria Feret, et al.
Publicado: (2021)